跳至主要内容
临床试验/NCT01908088
NCT01908088已完成1 期

Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane for Mitten Hand Deformity in Patients With Epidermolysis Bullosa

Royan Institute2 个研究点 分布在 2 个国家目标入组 6 人开始时间: 2010年7月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
6
试验地点
2
主要终点
Infection

研究概览

简要总结

Epidermolysis Bullosa (EB) is a blistering disease that is caused by defective anchoring fibrils and hemidesmosome in basement membrane of the skin layer. EB is inherited either autosomal or recessive and has 3 types. Recessive Dystrophic Epidermolysis Bullosa (RDEB) is severe with some morbidity such as mitten hand deformity.

The management of these patients is very difficult because no effective treatment has been known yet.

The EB patients with mitten hand deformity need surgery to have a biologic dressing for areas of hand which is without the skin. In this study the investigators assess the safety of autologous transplantation of cultured fibroblast on amniotic membrane (AM,as coverage) for them.

详细描述

Epidermolysis Bullosa patients with mitten hand deformity were included. (based on inclusion & exclusion criteria) These patients should be offered for surgery to release the adhesions between fingers and MCP. When the consent form was accepted and the lab test was confirmed, a small skin biopsy was removed from retro auricle and fibroblast cells were separated and cultured. These cells were seeded on AM and the microbial test was done as evidence to prove the safety.

Under general anesthesia, when the hands adhesion was removed, the autologous fibroblast cultured on AM was transplanted to the both hands (specially the area without skin coverage) and the hands were dressed afterward.

The dressing was changed and the wound was checked regularly to detect any complications.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Both genders Age: 5-25y No history of other systemic disease No history of other cell therapy method No infection in donor or recipient site HCV Ab/HIV Ab/ HBS Ag tests were negative

排除标准

  • Age less than 5y or more than 25y. History of other systemic disease History of other cell therapy method Infection in donor or recipient site Positive Lab tests for contagious viral diseases Pregnancy or lactating History of malignancy

研究组 & 干预措施

fibroblast transplant

Experimental

Transplantation of autologous cultured fibroblast on amniotic membrane in patients with Epidermolysis Bullosa with mitten hand deformity

干预措施: Cell transplantation (Biological)

结局指标

主要结局

Infection

时间窗: 1week

Evaluation the symptoms of any infection in the site of transplantation during 1week after transplantation.

Bleeding

时间窗: 1week

Evaluation the presence of any bleeding at the site of transplantation during 1 week after transplantation.

Healing

时间窗: 1month

Evaluation the healing of ulcers 1month after transplantation base on changing the dressing time.

Pain

时间窗: 1month

Evaluation the pain reduction 1 month after cell transplantation by VAS scoring.

次要结局

  • new ulceration(3months)
  • Range of motion(6months)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验